Withdrawal Research Studies

Confronting existential anxiety through “Basal Exposure Therapy” shows promising results in people withdrawing from psychotropic drugs.

Researchers interviewed doctors about the barriers that prevent them from being able to decrease excess medications.

Current long-term users of benzodiazepines and Z-drugs identify barriers and facilitators for discontinuation.

Study reviews psychological interventions for antidepressant discontinuation.

Psychiatrist and psychologist outline pharmacological and psychotherapeutic strategies for discontinuing antidepressants.

Findings point to the role of withdrawal symptoms and prescriber practices in long-term antidepressant use.

Meta-analysis of antidepressant tapering finds CBT and MBCT can aid in tapering, but limited studies met inclusion criteria.

New strategies for tapering psychiatric drugs achieved by acknowledging withdrawal symptoms and valuing service-users’ first-hand knowledge.

A new review of strategies to support both patients and practitioners through the process of discontinuing antidepressants.

Study reveals most patients are dissatisfied with prescribers' support when discontinuing antidepressants.

Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.

Researchers argue that common study methods for psychiatric drugs may inadvertently minimize withdrawal effects and inflate drug efficacy.

Review study compares outcomes of gradual vs. immediate antipsychotic discontinuation when switching from one drug to another.

“Short and simple psychological programs can prevent people from relapsing when they stop their antidepressants.”

A new study investigates how antidepressant withdrawal effects often get confounded with depression relapse in clinical trials.

A recently published study from noted critical psychiatry expert Joanna Moncrieff explored the barriers that prevent clinicians from helping service users in discontinuing or...

A new study to be published in the next issue of Schizophrenia Research examines patients suffering from a first-episode of psychosis who stop taking any antipsychotic drugs. The researchers attempt to identify variables that can serve as predictors of the successful discontinuation of antipsychotics. They find, for example, that those who discontinue the drugs have, on average, the same outcomes as those who stay on them, and that those who have better social integration are more likely to discontinue without relapse.

A new study explores how people manage to discontinue antipsychotic medication and examines how social supports may improve outcomes.

New research highlights the ethical responsibilities of clinicians in supporting patients who choose to reduce or discontinue antipsychotic medication.

Those using antidepressants long-term were more likely to experience withdrawal and to have severe withdrawal symptoms.

Instead of reducing risk, the dose reduction recommendation made by the FDA in their safety message was associated with an increase in hospitalizations.

Persistent antidepressant withdrawal is a debilitating experience, but little research exists about its prevalence and treatment.

Researchers identify simple ways for clinicians to begin deprescribing conversations.

Researchers from Germany, Greece and the U.S. reviewed the literature on relapse at 7 to 12 months following initiation of antipsychotic treatment. They conclude...

Drawing on analysis of data from websites such as Paxilprogress.org, ehealthforum.com, depression forums.org, about.com, medhelp.org, drugLib.com, topic.com and survivingantidepressants.org, researchers from the University of...